Unsuspected Acquired Haemophilia in a Patient with Myocardial Infarction

Evans E.N. , Majer R.V. Acquired haemophilia: an important but often unrecognised cause of bleeding in elderly people. BMJ 1995; 311: 679–81

Baudo F. , de Cataldo F. Acquired hemophilia: a critical bleeding syndrome. Haematologica 2004; 89: 96–100

Arkin S. , Blei F. , Fetten J. . Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors. Blood Coagul Fibrinolysis 2000; 11: 255–9

Kain S. , Copeland T.S. , Leahy M.F. Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab). Br J Haematol 2002; 119: 578

Wiestner A. , Cho H.J. , Asch A.S. . Rituximab in the treatment of acquired factor VIII inhibitors. Blood 2002; 100: 3426–8

Sallah S. , Wan J.Y. Efficacy of 2-chlorodeoxyadenosine in refractory factor VIII inhibitors in persons without hemophilia. Blood 2003; 101: 943–5